Home›Stock Screener›Medico Remedies

Medico Remedies Share Price Today | Stock Price & Medico Remedies Share Screener

MEDICO Pharmaceuticals
Live Share Price NSE
₹21.68
▼ -0.18 (-0.82%)
2026-10-05 00:00:00
Live Share Price BSE
₹21.83
▼ -0.17 (-0.77%)
2026-10-05 00:00:00

As of October 5, 2026, the live Medico Remedies share price (NSE: MEDICO) is ₹21.68 on NSE and ₹21.83 on BSE, down 0.82% from the previous close, with shares trading between ₹21.50 and ₹22.59 in today's trading session, and a 52-week range of ₹21.53–₹54.24. Check MEDICO 52-week high low for the annual price range and momentum. Use the Medico Remedies stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Medico Remedies opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹244 and net income of ₹14, with EBITDA of ₹24, an operating margin of 8.0% and a profit margin of 5.7%.

Medico Remedies Market Cap ₹181.24 Cr.
MEDICO P/E Ratio (TTM) 13.43
Medico Remedies P/B Ratio 2.45
EPS (TTM) ₹1.58
Dividend Yield -
Debt to Equity 0.24
MEDICO 52 Week High ₹54.24
Medico Remedies 52 Week Low ₹21.53
Operating Margin 8.00%
Profit Margin 5.74%
MEDICO Revenue (TTM) ₹244.00
EBITDA ₹24.00
Net Income ₹14.00
Total Assets ₹153.00
Total Equity ₹76.00

Medico Remedies Share Price Chart

Track the current stock price of Medico Remedies with an interactive chart. Analyse MEDICO share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Medico Remedies stock quote in one place.

The quote of ₹21.68 sits between the 52-week low of ₹21.53 and the 52-week high of ₹54.24, and the latest session moved -0.82% from the previous close.

Medico Remedies Company Profile - Fundamental Screener

Screen Medico Remedies company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MEDICO shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE630Y01024.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE630Y01024

Medico Remedies Balance Sheet Screener

Screen MEDICO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹153, up from ₹120 in 2025.

Latest statistics put total assets at ₹153 and shareholder funds at ₹76, with a leverage ratio of 0.24.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 153 120 96 87 77 76 75 76 59 48
Current Assets 129 97 74 65 58 59 57 59 46 38
Fixed Assets 20 21 22 22 18 15 13 12 7 7

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 0 0 1 2 3 5 5 3 3 11
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 76 63 52 44 37 33 30 28 27 16
Share Capital 17 17 17 17 17 4 4 4 4 3
Reserves & Surplus 59 46 36 27 20 28 26 24 23 13

Medico Remedies Income Statement Screener - Profit & Revenue Analysis

Screen Medico Remedies income statement and profit fundamentals. Analyze MEDICO quarterly results. Medico Remedies reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹244 and net profit was ₹14, equal to earnings per unit of ₹1.70, at an operating margin of 8%.

In that period expenses were ₹220, interest cost ₹2 and tax ₹5. The next period listed, 2026-March, shows revenue of ₹212 and net profit of ₹13.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 244 212 154 147 144 123 123 91 100 62 55 67 51
Expenses 220 189 136 132 131 114 117 86 95 58 50 63 48

Operating Costs and Margins

EBITDA 24 23 18 15 14 9 6 5 5 4 4 4 3
Operating Profit % 8.00% 8.00% 10.00% 9.00% 7.00% 6.00% 4.00% 3.00% 3.00% 6.00% 7.00% 5.00% 6.00%
Depreciation 3 3 3 3 3 2 2 2 2 1 1 1 1
Interest 2 2 1 1 1 1 1 1 1 2 1 1 1

Profit and Earnings

Profit Before Tax 19 18 14 11 10 7 4 2 2 2 2 2 1
Tax 5 5 3 3 3 2 1 1 1 1 0 1 0
Net Profit 14 13 10 8 7 5 3 2 2 1 2 1 1
EPS 1.70 1.58 1.22 1.00 0.87 0.58 1.56 3.93 3.78 3.65 5.09 3.53 5.91

Medico Remedies Cash Flow Screener - Liquidity Fundamentals

Screen MEDICO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹6, and net cash flow was an inflow of ₹1.

Over the same period, investing activities used ₹5 and financing activities used ₹1.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 6 5 2 8 6 -11 1 5 5 -3
Investing Activities -5 -4 -3 -7 -2 -17 -3 -4 -5 -3

Financing and Net Cash

Financing Activities -1 -1 -1 -2 -6 18 3 -1 -1 6
Net Cash Flow 1 1 -1 0 -2 -10 1 0 -1 0

Medico Remedies Shareholding Pattern Screener

See Medico Remedies shareholding pattern with promoter, FII, and DII holdings. Check Medico Remedies promoter holding and ownership changes for MEDICO on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 61.38%, foreign institutions 0.03%, domestic institutions 0.00% and the public 23.56%, spread across 16,189 shareholders.

The shareholder count was 16,189 in 2026-Mar, compared with 15,863 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 61.38% 61.38% 63.79% 62.59% 61.38% 61.38% 73.34% 73.34%

Institutional Investors

FII Holding 0.03% 0.08% 0.12% 0.07% 0.30% 0.49% 0.29% 0.23%
DII Holding 0.00% 0.00% 0.01% 0.01% 0.01% 0.00% 0.74% 0.97%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 23.56% 23.68% 22.13% 22.79% 23.11% 22.72% 14.39% 17.49%
Other Holding 15.03% 14.86% 13.94% 14.53% 15.19% 15.41% 11.24% 7.98%
Shareholder Count 16,189 15,863 15,424 16,474 18,503 16,562 10,685 12,902

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Medico Remedies. Medico Remedies dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Medico Remedies.

Medico Remedies Stock Index Membership - Nifty & Sensex

See which indices include Medico Remedies stock. Check MEDICO index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Medico Remedies is not part of any tracked indices.
Only major market indices are tracked in our system.

Medico Remedies Market Events Screener - Corporate Actions

Get Medico Remedies corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Medico Remedies stock events that may affect MEDICO share price, along with derivatives, futures and options activity and sector gainers.

13 corporate actions are listed, the most recent entry being Annual General Meeting dated September 22, 2026, with a record date of September 22, 2026.

It is followed by Quarterly Result Announcement dated August 13, 2026 and Quarterly Result Announcement dated May 21, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-22 2026-09-22 Annual General Meeting NA -19.59%
2026-08-13 2026-08-13 Quarterly Result Announcement NA 1.39%
2026-05-21 2026-05-21 Quarterly Result Announcement NA 6.05%
2026-02-12 2026-02-12 Quarterly Result Announcement NA 1.28%
2025-11-14 2025-11-14 Quarterly Result Announcement NA 7.58%
2025-09-08 2025-09-08 Annual General Meeting NA -0.25%
2025-08-08 2025-08-08 Quarterly Result Announcement NA -4.01%
2025-05-08 2025-05-08 Quarterly Result Announcement NA -5.84%
2025-02-05 2025-02-05 Quarterly Result Announcement NA 1.85%
2024-11-12 2024-11-12 Quarterly Result Announcement NA 4.05%
2024-09-05 2024-09-05 Annual General Meeting NA 20.82%
2023-03-16 2023-03-16 Split 2:10 16.61%
2021-11-16 2021-11-17 Bonus 3:1 -7.80%

Medico Remedies Competitors Screener - Peer Stocks Comparison

Screen MEDICO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 447,476 36.44 61,674 12.69% 11,565 47.42
Divis Laboratories 250,363 86.51 11,067 13.95% 2,568 58.71
Torrent Pharmaceuticals 186,152 85.91 13,886 20.34% 2,138 48.14
Zydus Life Science 120,798 26.32 27,658 17.64% 5,026 61.81
Cipla 111,426 33.44 29,045 2.24% 3,870 44.03
Laurus Labs 106,838 99.70 6,868 22.01% 890 58.00
Mankind Pharma 105,107 48.73 14,636 14.85% 1,938 64.24
Dr Reddys Laboratories 104,492 32.05 35,059 3.90% 4,158 69.59
Aurobindo Pharma 97,682 26.36 34,145 5.56% 3,503 54.69
Lupin 93,829 16.99 29,039 26.75% 5,356 34.02

Medico Remedies Company Announcements - News & Reports Screener

Screen MEDICO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated .

The next most recent announcements are dated September 29, 2026 and September 28, 2026.

Date Update Actions
Closure of Trading Window -
2026-09-29 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-28 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-29 Reg. 34 (1) Annual Report. -
2026-08-29 Intimation Of Book Closure Date Pursuant To Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-08-29 Submission Of Annual Report For The Financial Year 2025-26 Along With The Notice Of The 32Nd Annual General Meeting -
2026-08-17 Clarification On Price Movement -
2026-08-13 Financial Results For The Quarter Ended On 30Th June 2026 -
2026-08-10 Board Meeting Intimation for Intimation Of Board Meeting. -
2026-08-05 Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order -
2026-08-03 Clarification sought from Medico Remedies Ltd -
2026-06-30 Closure of Trading Window -
2026-06-29 Announcement under Regulation 30 (LODR)-Credit Rating -
2026-06-03 Intimation Of Action Taken Or Order Passed By Regulatory Statutory Enforcement Authority Or Judicial Body Under Regulation 30 (Read With Part B Of Schedule III) (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-05-21 Audited Standalone Financial Results Of The Company For The Quarter Ended 31St March 2026 And Audited Financial Statements For The Year Ended On 31St March 2026 Along With The AuditorS Report Thereon -
2026-05-21 Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 -
2026-05-21 Board Meeting Outcome for Outcome Of Board Meeting Held Today -
2026-05-15 Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Thursday 21St May 2026 -
2026-04-16 Intimation Of Action Taken Or Order Passed By Regulatory Statutory Enforcement Authority Or Judicial Body Under Regulation 30 (Read With Part B Of Schedule III) (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations) -
2026-02-24 Intimation Of Action Taken Or Order Passed By Regulatory Statutory Enforcement Authority Or Judicial Body Under Regulation 30 (Read With Part B Of Schedule III) (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations) -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹21.68, within a 52-week range of ₹21.53 to ₹54.24. The P/E ratio is 13.43 and the P/B ratio is 2.45, with earnings per unit of ₹1.58. Market capitalisation stands at ₹181.24 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.